Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

By TaChung Yu, Fangfang Guo, Yanan Yu, T. Sun, Dangdang Ma, Ji-Xuan Han, Yun Qian, Ilona Kryczek, Danfeng Sun, N. Nagarsheth and 5 more. Cell, 2017

1,913 citations recorded by the source corpus.

SUMMARY Gut microbiota are linked to chronic inflammation and carcinogenesis. Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer patients. Here, we investigated the contribution of gut microbiota to chemoresistance in patients with colorectal cancer. We found that Fusobacterium (F.) nucleatum was abundant in colorectal cancer tissues in patients with recurrence post chemotherapy, and was associated with patient clinicopathological characterisitcs. Furthermore, our bioinformatic and functional studies demonstrated that F. nucleatum promoted colorectal cancer resistance to chemotherapy. Mechanistically, F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter colorectal cancer chemotherapeutic response. Thus, F. nucleatum orchestrates a molecular network of the Toll-like receptor, micro-RNAs, and autophagy to clinically, biologically, and mechanistically control colorectal cancer chemoresistance. Measuring and targeting F. nucleatum and its associated pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer patient outcomes.

Subfields: Epidemiology, Molecular Biology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/0fe7a6127cd40c7b96801dba9d62bed6fbdffc53

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Curtis Huttenhower
2. Rob Knight
3. F. Greten
4. W. Garrett
5. L. Zitvogel
6. S. Grivennikov

In Molecular Biology

1. Curtis Huttenhower
2. Dirk Gevers
3. W. Garrett
4. Rob Knight
5. J. Wargo
6. Christoph A. Thaiss
7. A. Maitra
8. V. Gopalakrishnan

In Pharmacology

1. Rob Knight

Citations in the corpus

• The microbiome and human cancer (2021, background): “fragilis–derived toxin (22, 37, 38, 40, 41); (ii) CagA-mediated or IL-17– producing gd T cell–mediated inflammation in stomach and lung cancers, respectively (18, 103); (iii) chemoresistance through direct microbial metabolism (cytidine deaminase degradation of gemcitabine) in pancreatic cancer or i”
• Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine (2017, background): “This resistance mechanism is also distinct from a recent report of bacteria conferring drug resistance by the induction of tumor cell autophagy in colorectal cancer (22).”
• Inflammation and Cancer: Triggers, Mechanisms and Consequences (2019, background): “A common denominator for these bacteria is their presence in tightly adherent fraction of bacteria capable of direct interaction with the surface of the tumor, either because of special ligandreceptor mode of adhesion (Rubinstein et al., 2013; Yu et al., 2017), ability to form biofilms and initiate ”
• Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “Butyrate, an abundant bacterial metabolite, inhibits deacetylation of histones whereas certain species of bacteria can alter the non-coding RNA profile of host cells [210-212].”